Terra Nova Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-4,523
Closed -$232K 90
2022
Q4
$232K Buy
+4,523
New +$217K 0.24% 78
2022
Q3
Sell
-4,371
Closed -$229K 81
2022
Q2
$229K Buy
4,371
+34
+0.8% +$1.73K 0.25% 75
2022
Q1
$225K Buy
4,337
+253
+6% +$13.1K 0.21% 80
2021
Q4
$241K Buy
+4,084
New +$202K 0.18% 82
2017
Q1
Sell
-7,589
Closed -$234K 79
2016
Q4
$234K Buy
+7,589
New +$232K 0.47% 65
2016
Q2
Sell
-18,537
Closed -$521K 96
2016
Q1
$521K Hold
18,537
0.61% 61
2015
Q4
$568K Hold
18,537
0.63% 50
2015
Q3
$552K Buy
18,537
+359
+2% +$11.5K 0.49% 51
2015
Q2
$578K Buy
18,178
+184
+1% +$6K 0.47% 63
2015
Q1
$594K Buy
+17,994
New +$572K 0.49% 59

Other funds holding PFE

Terra Nova Asset Management's PFE Position: Q1 2023 in Review

Terra Nova Asset Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,523 shares — an estimated $232K sold.

Terra Nova Asset Management first reported a position in PFE in Q1 2015 and held it in 10 quarters. The position peaked at $594K in Q1 2015. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Terra Nova Asset Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Terra Nova Asset Management sold 4,523 Pfizer shares in Q1 2023, an estimated $232K.
  • Terra Nova Asset Management first reported a position in Pfizer in Q1 2015 and held it in 10 quarters.
  • Terra Nova Asset Management's Pfizer position peaked at $594K in Q1 2015.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Terra Nova Asset Management's 13F filing for Q1 2023, filed 13 Apr 2023.